In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has been applied to greatly advance our understanding of the specificity, and func-tional activity of antibodies against HIV. Thousands of antibodies have been generated and screened in functional neutralization assays, and antibodies associated with cross-strain neutralization and passive protection in primates, have been identified. To facilitate this type of discovery, a high throughput-screening tool is needed to accurately classify mAbs, and their antigen targets. In this study, we analyzed and evaluated a prototype microarray chip comprised of the HIV-1 recombinant proteins gp140, gp120, gp41, and several mem-brane proximal external region pep...
The identification and characterization of new human monoclonal antibodies (hMAbs) able to neutraliz...
The ability to induce anti-HIV-1 antibodies that can neutralize a broad spectrum of viral iso-lates ...
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that dire...
<div><p>In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs)...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
We used the microarray technology to develop chips containing a comprehensive set of proteins and pe...
textabstractOBJECTIVE: The aim of this study is to characterize antigenic sites on HIV-1 gp120 which...
The CD4 binding site (CD4bs) on the envelope glycoprotein is a major site of vulnerability that is c...
The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
The human antibody response against HIV-1 infection recognizes diverse antigenic sub-units of the vi...
AbstractAn effective vaccine against human immunodeficiency virus type 1 (HIV-1) will have to provid...
Lectin-like molecules and their receptors are cell surface molecules that have been shown to play a ...
HIV-1 envelope glycoproteins (Env) are the only viral antigens present on the virus surface and serv...
The identification and characterization of new human monoclonal antibodies (hMAbs) able to neutraliz...
The ability to induce anti-HIV-1 antibodies that can neutralize a broad spectrum of viral iso-lates ...
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that dire...
<div><p>In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs)...
In recent years, high throughput discovery of human recombinant monoclonal antibodies (mAbs) has bee...
We used the microarray technology to develop chips containing a comprehensive set of proteins and pe...
textabstractOBJECTIVE: The aim of this study is to characterize antigenic sites on HIV-1 gp120 which...
The CD4 binding site (CD4bs) on the envelope glycoprotein is a major site of vulnerability that is c...
The CD4 binding site (CD4BS) of the HIV-1 envelope glycoprotein (Env) contains epitopes for broadly ...
The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-...
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of ...
The human antibody response against HIV-1 infection recognizes diverse antigenic sub-units of the vi...
AbstractAn effective vaccine against human immunodeficiency virus type 1 (HIV-1) will have to provid...
Lectin-like molecules and their receptors are cell surface molecules that have been shown to play a ...
HIV-1 envelope glycoproteins (Env) are the only viral antigens present on the virus surface and serv...
The identification and characterization of new human monoclonal antibodies (hMAbs) able to neutraliz...
The ability to induce anti-HIV-1 antibodies that can neutralize a broad spectrum of viral iso-lates ...
Developing a vaccine that overcomes the diversity of HIV-1 is likely to require a strategy that dire...